US123 — Washington D.C., District of Columbia

US123 is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

US123 has participated in 2 clinical trials.

Therapeutic areas: Dementia With Lewy Bodies.

Sponsors: Axovant Sciences Ltd..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US123?

US123 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US123 conducted?

US123 has 2 clinical trials on record. Their work covers Dementia With Lewy Bodies.

Is US123 accredited by Crixeo Health?

US123 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US123?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.